Cargando…
Efficacy of NEMO-binding domain peptide used to treat experimental osteomyelitis caused by methicillin-resistant Staphylococcus aureus: an in-vivo study
PURPOSE: Treatment of chronic osteomyelitis (bone infection) remains a clinical challenge. Our previous study had demonstrated that NEMO-binding domain (NBD) peptide effectively ameliorates the inhibition of osteoblast differentiation by TNF-α in vitro. In this work, NBD peptide was evaluated in viv...
Autores principales: | Xu, Chang-Peng, Chen, Ya, Sun, Hong-Tao, Cui, Zhuang, Yang, Ya-Jun, Huang, Lei, Yu, Bin, Wang, Fa-Zheng, Yang, Qing-Po, Qi, Yong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6864959/ https://www.ncbi.nlm.nih.gov/pubmed/31832182 http://dx.doi.org/10.1186/s13756-019-0627-y |
Ejemplares similares
-
Resolution of Staphylococcus aureus (methicillin-resistant Staphylococcus aureus) osteomyelitis by oral linezolid
por: Gomes, PN, et al.
Publicado: (2003) -
Activity of Omadacycline in Rat Methicillin-Resistant Staphylococcus aureus Osteomyelitis
por: Karau, Melissa J., et al.
Publicado: (2022) -
Treatment of Methicillin-resistant Staphylococcus aureus experimental Osteomyelitis with bone-targeted Vancomycin
por: Karau, Melissa J, et al.
Publicado: (2013) -
The effects of NF-κB inhibition by a NEMO binding domain peptide in vitro and in vivo
por: Tas, SW, et al.
Publicado: (2004) -
Comparison of Functional Protein Transduction Domains Using the NEMO Binding Domain Peptide
por: Khaja, Khaleel, et al.
Publicado: (2010)